Goldman Sachs’s Autolus Therapeutics AUTL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$55K Sell
24,106
-26,305
-52% -$60K ﹤0.01% 4964
2025
Q1
$78.1K Sell
50,411
-75,819
-60% -$118K ﹤0.01% 4864
2024
Q4
$297K Buy
126,230
+66,218
+110% +$156K ﹤0.01% 4533
2024
Q3
$218K Sell
60,012
-18,352
-23% -$66.6K ﹤0.01% 4463
2024
Q2
$273K Sell
78,364
-137,977
-64% -$480K ﹤0.01% 4253
2024
Q1
$1.38M Buy
216,341
+84,610
+64% +$540K ﹤0.01% 3417
2023
Q4
$848K Buy
131,731
+64,910
+97% +$418K ﹤0.01% 3689
2023
Q3
$156K Sell
66,821
-26,374
-28% -$61.5K ﹤0.01% 4310
2023
Q2
$222K Buy
93,195
+71,378
+327% +$170K ﹤0.01% 4358
2023
Q1
$40.1K Buy
+21,817
New +$40.1K ﹤0.01% 4795
2022
Q4
Sell
-18,851
Closed -$40K 5152
2022
Q3
$40K Sell
18,851
-2,188
-10% -$4.64K ﹤0.01% 5059
2022
Q2
$60K Sell
21,039
-354,475
-94% -$1.01M ﹤0.01% 5242
2022
Q1
$1.57M Buy
375,514
+222,093
+145% +$926K ﹤0.01% 3753
2021
Q4
$796K Buy
153,421
+97,030
+172% +$503K ﹤0.01% 4209
2021
Q3
$369K Sell
56,391
-594,105
-91% -$3.89M ﹤0.01% 4545
2021
Q2
$4.32M Buy
650,496
+639,002
+5,559% +$4.24M ﹤0.01% 2889
2021
Q1
$66K Sell
11,494
-2,891
-20% -$16.6K ﹤0.01% 5099
2020
Q4
$129K Sell
14,385
-13,189
-48% -$118K ﹤0.01% 4419
2020
Q3
$321K Sell
27,574
-7,058
-20% -$82.2K ﹤0.01% 3870
2020
Q2
$555K Sell
34,632
-3,756
-10% -$60.2K ﹤0.01% 3543
2020
Q1
$230K Buy
38,388
+27,672
+258% +$166K ﹤0.01% 3884
2019
Q4
$141K Sell
10,716
-13,295
-55% -$175K ﹤0.01% 4072
2019
Q3
$298K Buy
+24,011
New +$298K ﹤0.01% 3793
2019
Q2
Sell
-8,720
Closed -$274K 4173
2019
Q1
$274K Buy
8,720
+2,026
+30% +$63.7K ﹤0.01% 3777
2018
Q4
$220K Buy
+6,694
New +$220K ﹤0.01% 3705